Cite
MLA Citation
S Al Draiweesh et al.. “DOP39 Safety of combination biologic and anti-rejection therapy post-liver transplantation in patients with inflammatory bowel disease: London Ontario experience.” Journal of Crohn's and colitis, vol. 13, n.d., pp. S048–S049. http://access.bl.uk/ark:/81055/vdc_100092357327.0x00000b